Your browser doesn't support javascript.
loading
[Nausea and vomiting in pregnancy: A place for ondansetron?] / Nausées et vomissements gravidiques : quelle place pour l'ondansétron ?
Coulm, B.
Afiliación
  • Coulm B; DMU ESPRIT (épidémiologie et biostatistique, santé publique, pharmacie, pharmacologie, recherche, information médicale, thérapeutique et médicaments), centre de référence sur les agents tératogènes (CRAT), GHU, Sorbonne université, AP-HP, site Trousseau, 26, avenue Docteur-Netter, 75571 Paris cedex 12, France. Electronic address: benedicte.coulm@aphp.fr.
Gynecol Obstet Fertil Senol ; 49(12): 947-950, 2021 12.
Article en Fr | MEDLINE | ID: mdl-34700033
ABSTRACT
Although there is no recommendation in France relating to the treatment of nausea and vomiting of pregnancy, there are some in other countries, where ondansetron, widely used, appears to be an effective second-line treatment option behind doxylamine/vitamin B6 association and metoclopramide. However, based on some recent publication suggesting an increased risk of orofacial clefts and congenital heart defects in fetuses exposed in utero to ondansetron in the 1st trimester of pregnancy, the European Medicines Agency now states that this drug should not longer be used during this period. This 2019 decision is controversial and whether ondansetron can be used in pregnant women with severe vomiting during pregnancy is still in question.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Labio Leporino / Fisura del Paladar / Antieméticos Tipo de estudio: Guideline Límite: Female / Humans / Pregnancy Idioma: Fr Revista: Gynecol Obstet Fertil Senol Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Labio Leporino / Fisura del Paladar / Antieméticos Tipo de estudio: Guideline Límite: Female / Humans / Pregnancy Idioma: Fr Revista: Gynecol Obstet Fertil Senol Año: 2021 Tipo del documento: Article